Dupont Jakob
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to Dupont Jakob. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PYXS | Award / Grant | 38,741 | — | — | Mar 26, 2024 | |
| ATRA | EVP, Head of R&D | Sale | 5,074 | $3.63 | $18,419 | Mar 2, 2023 |
| ATRA | EVP, Head of R&D | Award / Grant | 141,328 | — | — | Mar 1, 2023 |
| ATRA | EVP, Head of R&D | Sale | 1,124 | $4.49 | $5,047 | Nov 16, 2022 |
| ATRA | EVP, Head of R&D | Sale | 4,124 | $5.03 | $20,744 | Aug 16, 2022 |
| ATRA | EVP, Head of R&D | Sale | 3,873 | $5.32 | $20,604 | May 17, 2022 |
| ATRA | EVP, Head of R&D | Award / Grant | 78,506 | — | — | Mar 1, 2022 |
| ATRA | EVP, Head of R&D | Option Exercise | 5,000 | $9.58 | $47,900 | Feb 10, 2022 |
| ATRA | EVP, Head of R&D | Sale | 5,000 | $16.01 | $80,050 | Jan 3, 2022 |
| ATRA | EVP, Head of R&D | Sale | 5,000 | $17.94 | $89,700 | Dec 1, 2021 |
| ATRA | EVP, Head of R&D | Sale | 2,199 | $17.12 | $37,647 | Nov 16, 2021 |
| ATRA | EVP, Head of R&D | Option Exercise | 5,000 | $9.58 | $47,900 | Nov 2, 2021 |
| ATRA | EVP, Head of R&D | Sale | 2,152 | $12.53 | $26,965 | Aug 17, 2021 |
| ATRA | EVP, Head of R&D | Sale | 5,184 | $14.55 | $75,427 | May 18, 2021 |
| ATRA | EVP, Head of R&D | Award / Grant | 53,879 | — | — | Mar 1, 2021 |
| ATRA | EVP, Head of R&D | Award / Grant | 46,250 | — | — | May 14, 2020 |
| GOSS | Chief Medical Officer | Award / Grant | 46,500 | — | — | Feb 14, 2020 |
| GOSS | Chief Medical Officer | Option Exercise | 1,994 | $10.71 | $21,356 | Dec 30, 2019 |
| 0001302573 | SVP & Chief Medical Officer | Award / Grant | 12,500 | — | — | Oct 9, 2016 |
| 0001302573 | SVP & Chief Medical Officer | Option Exercise | 2,500 | $4.56 | $11,400 | Jan 11, 2016 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 2,092 | $22.30 | $46,652 | Jan 6, 2016 |
| 0001302573 | SVP & Chief Medical Officer | Option Exercise | 2,500 | $4.56 | $11,400 | Dec 10, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 2,500 | $21.17 | $52,925 | Nov 10, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 5,000 | $20.00 | $100,000 | Oct 26, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Option Exercise | 2,500 | $4.56 | $11,400 | Aug 10, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 2,500 | $20.13 | $50,325 | Jul 10, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 2,500 | $21.22 | $53,050 | Jul 6, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 1,500 | $26.51 | $39,765 | Apr 10, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Option Exercise | 1,500 | $4.56 | $6,840 | Mar 10, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 1,500 | $24.23 | $36,345 | Feb 10, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 400 | $26.62 | $10,648 | Jan 12, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 7,500 | $23.00 | $172,500 | Jan 5, 2015 |
| 0001302573 | SVP & Chief Medical Officer | Sale | 1,500 | $23.00 | $34,500 | Jul 23, 2014 |
| 0001302573 | SVP & Chief Medical Officer | Option Exercise | 1,500 | $4.56 | $6,840 | Jun 26, 2014 |
| 0001302573 | SVP & Chief Medical Officer | Award / Grant | 20,000 | — | — | Mar 25, 2014 |